Literature DB >> 15037981

[Screening and Measurement of Change of Dissociative Psychopathology: Psychometric Properties of the Short Version of the Fragebogen zu Dissoziativen Symptomen (FDS-20)].

Carsten Spitzer1, Robert Mestel, Jürgen Klingelhöfer, Michael Gänsicke, Harald J Freyberger.   

Abstract

Given the clinical and scientific relevance of dissociative experiences our study aimed to assess the psychometric properties of a short version of the German Dissociative Experience Scale (called FDS-20) as well as its ability to measure changes in dissociation. In a large sample (N = 1289) the FDS- 20 showed good internal consistency. A factor analysis indicated that the scale measures one single factor reflecting the general degree of dissociative psychopathology. Between-group-comparisons suggested a good discriminant validity between high and low dissociators; however, due to high standard deviations the FDS-20 is not well suited for an individual diagnosis and therefore, it should be used as a screening device. Low effect sizes (d < 0,3) between scores at the beginning and the end of inpatient treatment as well as low micro -indices pointed to a temporal stable construct and a trait scale, respectively. Alternatively to group comparisons, individual parameters of treatment success (statistical and clinical significance) were calculated. They proved to be more appropriate in measuring changes in dissociation.

Mesh:

Year:  2004        PMID: 15037981     DOI: 10.1055/s-2003-814783

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  8 in total

1.  Translation and validation of the German version of the weight self-stigma questionnaire (WSSQ).

Authors:  Bernhard Hain; Lorena Langer; Katharina Hünnemeyer; Gottfried Rudofsky; Ulrike Zech; Beate Wild
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

2.  White matter network alterations in patients with depersonalization/derealization disorder.

Authors:  Anika Sierk; Judith K Daniels; Antje Manthey; Jelmer G Kok; Alexander Leemans; Michael Gaebler; Jan-Peter Lamke; Johann Kruschwitz; Henrik Walter
Journal:  J Psychiatry Neurosci       Date:  2018-08       Impact factor: 6.186

3.  Neural correlates of acute post-traumatic dissociation: a functional neuroimaging script-driven imagery study.

Authors:  Yoki L Mertens; Antje Manthey; Anika Sierk; Henrik Walter; Judith K Daniels
Journal:  BJPsych Open       Date:  2022-06-10

4.  State dissociation moderates response to dialectical behavior therapy for posttraumatic stress disorder in women with and without borderline personality disorder.

Authors:  Nikolaus Kleindienst; Kathlen Priebe; Nora Görg; Anne Dyer; Regina Steil; Lisa Lyssenko; Dorina Winter; Christian Schmahl; Martin Bohus
Journal:  Eur J Psychotraumatol       Date:  2016-07-06

5.  Impact of therapist change after initial contact and traumatic burden on dropout in a naturalistic sample of inpatients with borderline pathology receiving dialectical behavior therapy.

Authors:  Carolin Steuwe; Michaela Berg; Martin Driessen; Thomas Beblo
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2017-06-22

6.  Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial.

Authors:  Carolin Steuwe; Michaela Berg; Thomas Beblo; Martin Driessen
Journal:  Front Psychiatry       Date:  2021-11-26       Impact factor: 4.157

7.  Differences in trauma history and psychopathology between PTSD patients with and without co-occurring dissociative disorders.

Authors:  Pascal Wabnitz; Ursula Gast; Claudia Catani
Journal:  Eur J Psychotraumatol       Date:  2013-11-26

8.  Dialectical behaviour therapy for posttraumatic stress disorder related to childhood sexual abuse: a pilot study in an outpatient treatment setting.

Authors:  Regina Steil; Clara Dittmann; Meike Müller-Engelmann; Anne Dyer; Anne-Marie Maasch; Kathlen Priebe
Journal:  Eur J Psychotraumatol       Date:  2018-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.